National Vision Holdings, Inc. — Form 10-K Summary
Period and filing scope: The supplied filing is the annual report for fiscal 2022, the 52 weeks ended December 31, 2022, compared primarily with fiscal 2021, the 52 weeks ended January 1, 2022. This does not match the request metadata “2021 Q4”; the text does not provide stand-alone fourth-quarter financial results.
Business context
National Vision is a value-focused U.S. optical retailer selling eyeglasses, contact lenses and eye exams through America’s Best, Eyeglass World, host locations and Walmart Vision Centers. At year-end it operated 1,354 stores, up from 1,278, and opened 80 stores during the year. It also operates e-commerce and managed-care businesses; digital and e-commerce sales were 11.2% of 2022 revenue, versus 10.5% in 2021.
Key financial results
| Metric | FY2022 | FY2021 | Change |
|---|---|---|---|
| Net revenue | $2,005.4 million | $2,079.5 million | Down 3.6% |
| Income from operations | $61.3 million | $174.9 million | Down 65.0% |
| Net income | $42.1 million | $128.2 million | Down 67.2% |
| Diluted EPS | $0.52 | $1.43 | Down 63.6% |
| Adjusted EBITDA | $180.3 million | $294.4 million | Down 38.8% |
| Operating cash flow | $119.2 million | $258.9 million | Down $139.7 million |
| Capital expenditures | $113.5 million | $95.5 million | Up $18.0 million |
Margins and cost trends: Costs applicable to revenue rose to 46.2% of sales from 43.5%, implying a gross margin of approximately 53.8% versus 56.5%. SG&A increased to 45.6% of revenue from 43.3%. Operating margin fell to 3.1% from 8.4%; net margin was 2.1% versus 6.2%. Management attributed pressure chiefly to optometrist-related costs, lower eyeglass mix and margin, payroll and occupancy expense, and lower sales leverage.
Sales performance: Comparable-store sales declined 7.5% (adjusted comparable-store sales declined 7.6%), following strong growth in 2021. Management cited fewer customer transactions, lower average ticket, economic pressure, exam-capacity constraints and the Omicron variant. Eyeglass sales fell 6.7%; contact-lens sales rose 1.7%. Walmart-related sales represented 7.6% of consolidated revenue.
Cash, liquidity and debt: Year-end cash and cash equivalents were $229.4 million, down from $305.8 million. Revolver availability was $293.6 million, net of $6.4 million in letters of credit. Operating cash flow less capital expenditures was approximately $5.7 million, calculated from reported figures. Principal debt totaled $552.5 million: $150.0 million of variable-rate term debt due in 2024 and $402.5 million of 2.50% convertible notes due in 2025. The term-loan rate averaged 3.1%; the company reported compliance with debt covenants. The notes could be convertible under specified conditions, creating potential dilution. The balance sheet also reports substantial lease obligations.
Material changes, outlook and notable items
- Revenue declined modestly, but profitability and operating cash flow fell substantially as margins compressed and expenses remained elevated. Adjusted EBITDA margin declined to 9.0% from 14.2%.
- Net interest expense was only $0.5 million, versus $25.6 million in 2021, primarily because of lower derivative costs and a $18.0 million gain on the interest-rate collar. Cash interest paid was $16.9 million; reported interest expense should not be read as equivalent to cash interest.
- The effective tax rate increased to 30.7% from 14.1%; the prior-year rate benefited from stock-option tax effects and the matured interest-rate swaps.
- Management described continued inflation, labor-market pressure and optometrist shortages. It raised America’s Best’s two-pair offer from $69.95 to $79.95 in May 2022 and Eyeglass World’s opening offer from $78 to $89 in March 2022. The filing provides no revenue or earnings guidance.
- Management estimated FY2023 capital expenditures of $115–$120 million, primarily for new stores, remote medicine, electronic health records, laboratories and IT. The company opened 80 stores in 2022 and had remote medicine enabled in about 300 America’s Best locations.
- The Walmart management agreement runs through February 23, 2024, with automatic renewal for three years unless either party gives notice by July 2023. The Legacy segment’s goodwill fair value exceeded carrying value by about 9%; the filing notes sensitivity to customer concentration and valuation assumptions.
- The company repurchased 2.7 million shares for $80.0 million in 2022; about $50 million remained under its authorization at year-end. It has no current plan to pay dividends.
- Disclosed litigation includes a proposed California wage-and-hour class action and a securities class action filed in January 2023; the company disputes the claims. Auditors issued unqualified opinions on the financial statements and internal controls, while identifying Legacy goodwill valuation as a critical audit matter.
Important facts for investors to verify
- Whether comparable-store sales and customer transactions recover, and whether optometrist availability improves without further margin pressure.
- Whether operating cash flow can fund planned capital spending, lease commitments, repurchases and debt service; assess refinancing or repayment capacity ahead of 2024–2025 maturities.
- Whether the Walmart agreement renewed, and whether Legacy performance or valuation changes affect goodwill or cash flows.
- How convertible-note settlement could affect dilution and share count, and how derivative gains or losses affect reported earnings and cash generation.
- Developments in the disclosed lawsuits, supplier concentration, and other regulatory, privacy, labor and consumer-demand risks.